Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-nrsn
/
Neurosense Therapeutics Ltd
NRSN
1.220
USD
+0.010
+0.83%
Close 09/19, 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
30.01M
Market Cap
Loss
P/E TTM
Neurosense Therapeutics Ltd
1.220
+0.010
+0.83%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating expenses
-19.76%
2.11M
-10.09%
3.03M
0.10%
2.99M
-2.72%
3.29M
-20.88%
2.63M
-6.13%
3.37M
-8.36%
2.99M
--
3.38M
--
3.32M
--
3.59M
--
3.26M
R&D expenses
-25.48%
1.16M
-19.87%
1.57M
1.62%
1.88M
26.81%
1.96M
-8.68%
1.56M
4.71%
1.96M
42.90%
1.85M
--
1.54M
--
1.71M
--
1.87M
--
1.30M
Operating profit
19.76%
-2.11M
10.09%
-3.03M
-0.10%
-2.99M
2.72%
-3.29M
20.88%
-2.63M
6.13%
-3.37M
8.36%
-2.99M
--
-3.38M
--
-3.32M
--
-3.59M
--
-3.26M
Net non-operating interest income (expenses)
Non-operating interest income
--
--
--
2.17M
--
--
64.08%
338.00K
579.40%
2.28M
--
--
-88.29%
67.00K
--
206.00K
--
335.00K
--
144.00K
--
572.00K
Non-operating interest expense
--
41.00K
--
--
--
2.41M
--
1.00K
--
--
688.57%
276.00K
--
--
--
--
--
10.00K
--
35.00K
--
23.00K
Gains from sale of securities
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
23.00K
--
--
--
--
--
--
Income before tax
-513.71%
-2.15M
76.49%
-857.00K
-84.82%
-5.40M
6.35%
-2.95M
88.31%
-350.00K
-4.74%
-3.65M
-7.70%
-2.92M
--
-3.15M
--
-2.99M
--
-3.48M
--
-2.71M
Income after tax
-513.71%
-2.15M
76.49%
-857.00K
-84.82%
-5.40M
6.35%
-2.95M
88.31%
-350.00K
-4.74%
-3.65M
-7.70%
-2.92M
--
-3.15M
--
-2.99M
--
-3.48M
--
-2.71M
Net income from continuous operations
-513.71%
-2.15M
76.49%
-857.00K
-84.82%
-5.40M
6.35%
-2.95M
88.31%
-350.00K
-4.74%
-3.65M
-7.70%
-2.92M
--
-3.15M
--
-2.99M
--
-3.48M
--
-2.71M
Net income attributable to controlling interests
-513.71%
-2.15M
76.49%
-857.00K
-84.82%
-5.40M
6.35%
-2.95M
88.31%
-350.00K
-4.74%
-3.65M
-7.70%
-2.92M
--
-3.15M
--
-2.99M
--
-3.48M
--
-2.71M
Net income attributable to common shareholders
-513.71%
-2.15M
76.49%
-857.00K
-84.82%
-5.40M
6.35%
-2.95M
88.31%
-350.00K
-4.74%
-3.65M
-7.70%
-2.92M
--
-3.15M
--
-2.99M
--
-3.48M
--
-2.71M
Basic earnings per share
-336.29%
-0.11
84.51%
-0.05
-41.39%
-0.35
35.44%
-0.17
90.08%
-0.03
-1.61%
-0.31
-0.47%
-0.25
--
-0.27
--
-0.26
--
-0.30
--
-0.25
Diluted earnings per share
-336.29%
-0.11
84.51%
-0.05
-41.39%
-0.35
35.44%
-0.17
90.08%
-0.03
-1.61%
-0.31
-0.47%
-0.25
--
-0.27
--
-0.26
--
-0.30
--
-0.25
Dividend per share
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up